Single cell 3-D platform to study ligand mobility in cell-cell contact.

Understanding how cells interact with their environment is central to cell biology. While the lateral mobility of cell adhesion molecules has been studied, its effects in a controlled three-dimensional setting remain unclear. Prior research has shown that the dimensionality of adhesion ligands influences cell behavior. However, no prior work had resolved how these effects manifest in a realistic in vitro system. The ability to manipulate ligand mobility in a spatially defined way is still limited. Current platforms lack the capacity to mimic the dynamic nature of cell-cell interactions in a three-dimensional context. This gap motivated the development of a new platform that can control lateral ligand mobility. The study addresses the need to understand how ligand fluidity affects adhesion and cytoskeletal organization. By bridging this gap, researchers can better model cell behavior in complex environments.

The aim of this study was to develop an in vitro platform that allows precise control over the lateral mobility of cell adhesion ligands in a three-dimensional setting. The researchers sought to investigate how this mobility affects cell adhesion and cytoskeletal dynamics. They focused on E-cadherin, a key adhesion molecule, and aimed to present it in either a mobile or immobile state. The platform was designed to mimic the spatial organization of neighboring cells in a reductionist way. By using a cell membrane mimetic surface, the study aimed to replicate the native cell environment. The researchers also wanted to test whether changes in ligand mobility could influence actin organization. This approach allows for a controlled comparison of adhesion outcomes under different mobility conditions. The study's motivation was to provide a new tool for studying cell-cell interactions in a more realistic setting.

The researchers developed a platform using microwells with a pre-patterned cell membrane mimetic interface. This interface was based on a supported phospholipid bilayer (SPB) functionalized with E-cadherin extracellular domains. The SPB was linked to the microwell walls via a streptavidin-antibody system. The lateral mobility of E-cadherin was controlled by adjusting the lipid composition of the SPB. Phospholipids with a phase transition temperature around 30°C were selected to allow fluidity changes with small temperature shifts. The platform enabled the presentation of either mobile or immobile ligands on the same surface. CHO cells engineered to express E-cadherin were cultured on the platform to observe adhesion and actin organization. The study focused on how ligand mobility influenced cytoskeletal dynamics in a three-dimensional setting.

Cells cultured on the platform showed distinct differences in actin organization depending on ligand mobility. When E-cadherin was presented as a mobile ligand, actin bundles were less prominent and more diffuse. In contrast, immobile ligands led to increased actin bundling. The cell shape was constrained by the microwell geometry in both cases. The study found that enhanced cadherin lateral mobility significantly decreased actin bundle formation. These results suggest that ligand mobility plays a critical role in cytoskeletal organization. The temperature-controlled lipid system allowed precise manipulation of ligand fluidity. The platform successfully mimicked cell-cell interactions in a three-dimensional context. These findings highlight the importance of ligand mobility in cell adhesion dynamics.

The study demonstrates that the lateral mobility of E-cadherin ligands affects actin organization in cultured cells. The platform enabled a controlled comparison of mobile versus immobile ligands in a three-dimensional setting. The results suggest that ligand mobility influences cytoskeletal dynamics, as shown by differences in actin bundling. The platform successfully mimicked the spatial and dynamic aspects of cell-cell interactions. The use of a temperature-sensitive lipid system allowed precise control over ligand fluidity. These findings support the potential of in vitro platforms to study cell adhesion in a more realistic environment. The study does not propose new drug targets or future directions beyond the platform's application. The authors suggest that this approach can be used to further investigate cell behavior in controlled settings.